Holen Sie sich die Stockscreener-App
8.76
4.16%
0.35
Handel nachbörslich:
8.66
-0.10
-1.14%
Schlusskurs vom Vortag:
$8.41
Offen:
$8.35
24-Stunden-Volumen:
22,318
Relative Volume:
0.27
Marktkapitalisierung:
$53.91M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-0.3607
EPS:
-24.2853
Netto-Cashflow:
$-85.33M
1W Leistung:
-3.95%
1M Leistung:
-12.31%
6M Leistung:
+11.73%
1J Leistung:
-80.80%
1-Tages-Spanne:
$8.35
$8.90
1-Wochen-Bereich:
$8.25
$9.9999
52-Wochen-Spanne:
$3.76
$46.31
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Firmenname
Aligos Therapeutics Inc
Sektor
Branche
Telefon
(800) 466-6059
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Vergleichen Sie ALGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
8.76 | 51.75M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-08-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2021-09-09 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-17 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-11-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten
(ALGS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Is Aligos Therapeutics Inc a good long term investmentValue Traps to Avoid & Diversify Intelligently to Avoid Big Hits - earlytimes.in
Head to Head Review: Xilio Therapeutics (NASDAQ:XLO) and Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Aug PreEarnings: How Aligos Therapeutics Inc 5WK0 stock reacts to fiscal policies2025 Pullback Review & Low Drawdown Momentum Trade Ideas - moha.gov.vn
Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 4.5% – Time to Sell? - Defense World
Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 4.5%Time to Sell? - MarketBeat
Aligos Therapeutics secures $105 million in private placement - MSN
Technical Reactions to ALGS Trends in Macro Strategies - Stock Traders Daily
Why Aligos Therapeutics Inc. stock could be next big winnerMarket Weekly Review & Weekly High Momentum Picks - Улправда
Analyst Calls: Why Aligos Therapeutics Inc. stock is rated strong buyJuly 2025 Decliners & Community Consensus Trade Signals - DonanımHaber
Why Aligos Therapeutics Inc. stock is a must watch in 20252025 Trade Ideas & Free Fast Gain Swing Trade Alerts - DonanımHaber
Aligos Therapeutics Earnings Notes - Trefis
How resilient is Aligos Therapeutics Inc. stock in market downturnsWeekly Investment Report & Capital Efficiency Focused Ideas - DonanımHaber
Why analysts upgrade Aligos Therapeutics Inc. stockTrade Volume Report & Free Growth Oriented Trading Recommendations - Улправда
Gainers Report: Does Aligos Therapeutics Inc stock trade at a discount to peers2025 Technical Overview & Expert Approved Momentum Ideas - moha.gov.vn
Hepatitis B Virus Infection Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Globe and Mail
(ALGS) and the Role of Price-Sensitive Allocations - Stock Traders Daily
What analysts say about Aligos Therapeutics Inc stockPrice-to-Earnings Ratio Insights & Minimal Investment Portfolio - earlytimes.in
Aligos Therapeutics, Inc. (ALGS) Fundamental Analysis - Meyka
Aligos Therapeutics (ALGS) Issues Stock Options to New Employees - GuruFocus
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Aligos reports synergistic weight loss effect with THR-β agonist By Investing.com - Investing.com South Africa
Aligos reports synergistic weight loss effect with THR-β agonist - Investing.com
Aligos Therapeutics (ALGS) Unveils Promising Data at HEP-DART 20 - GuruFocus
Aligos Therapeutics Highlights Positive Data on Pevifoscorvir Sodium and ALG-055009 at HEP-DART 2025 Meeting - Quiver Quantitative
Aligos Therapeutics, Inc. Presents Positive Data at HEP-DART 2025 - marketscreener.com
Aligos Therapeutics (NASDAQ:ALGS) Will Have To Spend Its Cash Wisely - Sahm
Contrasting Neurogene (NASDAQ:NGNE) & Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Can Aligos Therapeutics Stock Recover If Markets Fall? - Trefis
Reviewing Aligos Therapeutics (NASDAQ:ALGS) and ANI Pharmaceuticals (NASDAQ:ANIP) - Defense World
Why Aligos Therapeutics Inc. (5WK0) stock could be next leaderWeekly Trend Summary & Safe Capital Growth Plans - Newser
How supply shortages influence Aligos Therapeutics Inc. (5WK0) stockJuly 2025 Gainers & Low Drawdown Investment Strategies - Newser
What dividend safety rating applies to Aligos Therapeutics Inc. (5WK0) stockGold Moves & AI Driven Stock Movement Reports - Newser
Can Aligos Therapeutics Inc. (5WK0) stock sustain margin levelsJuly 2025 Highlights & Verified Entry Point Signals - Newser
What is the fair value estimate for Aligos Therapeutics Inc. (5WK0) stock in 2025Gap Down & Long-Term Capital Growth Strategies - Newser
Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosJuly 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Why Aligos Therapeutics Inc. stock is a value investor pickJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Can Aligos Therapeutics Inc. stock beat market expectations this quarter2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Will Aligos Therapeutics Inc. (5WK0) stock split increase liquidityMarket Movers & Free Real-Time Volume Trigger Notifications - Newser
Responsive Playbooks and the ALGS Inflection - news.stocktradersdaily.com
Sio Capital Management LLC Increases Stock Position in Aligos Therapeutics, Inc. $ALGS - MarketBeat
Piper Sandler Reaffirms Their Buy Rating on Aligos Therapeutics (ALGS) - The Globe and Mail
Aligos Therapeutics Stock Rockets 57% With 7-Day Winning Streak - Trefis
Understanding the Setup: (ALGS) and Scalable Risk - news.stocktradersdaily.com
Is Aligos Therapeutics Inc. (5WK0) stock a good hedge against inflationJuly 2025 Sector Moves & Breakout Confirmation Alerts - newser.com
Why Aligos Therapeutics Inc. stock could outperform in 2025Market Growth Summary & AI Optimized Trade Strategies - newser.com
Transcript : Aligos Therapeutics, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-17-2025 03 - MarketScreener
Is Aligos Therapeutics Inc. stock undervalued vs historical averagesEntry Point & Entry Point Confirmation Alerts - newser.com
What moving averages say about Aligos Therapeutics Inc.2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):